MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
December 29, 2021

Ivosidenib Safe, Efficactive in Early Myelodysplastic Syndrome Trial

By Andrew John, MD /alert Contributor
Monotherapy with ivosidenib was efficacious and well-tolerated in patients with myelodysplastic syndrome...
Ivosidenib Safe, Efficactive in Early Myelodysplastic Syndrome Trial
December 28, 2021

FDA Approves Rituximab for Pediatric Cancer Patients

By Adam Hochron, Staff Writer
The FDA approved rituximab combined with chemotherapy for children between 6 months and 18 years with previously untreated, advanced stage CD20-positive diffuse large B-cell lymphoma, Burkitt lymphoma, Burkitt-like lymphoma, or mature B-cell acute leukemia...
FDA Approves Rituximab for Pediatric Cancer Patients
December 27, 2021

Combination Vemurafenib, Obinutuzumab Yields High Rate of Complete Remission In Untreated Hairy Cell Leukemia

By Jeff Craven, MD /alert Contributor
Patients with hairy cell leukemia had a complete response rate of 100% and 96% had undetectable minimal residual disease at median 16.7 months of follow-up after receiving vemurafenib and obinutuzumab...
Combination Vemurafenib, Obinutuzumab Yields High Rate of Complete Remission In Untreated Hairy Cell Leukemia
December 23, 2021

Standing More Increases Insulin Sensitivity in Postmenopausal Women

By Adam Hochron, Staff Writer
A randomized, crossover intervention study confirmed previous research that standing more and walking can help improve the metabolic health of postmenopausal women with insulin sensitivity...
Standing More Increases Insulin Sensitivity in Postmenopausal Women
December 22, 2021

FDA Grants Orphan Drug Designation to BCMA/CD19-Targeting CAR-T Therapy for Multiple Myeloma Treatment

By Adam Hochron, Staff Writer
The FDA granted orphan drug designation to GC012F, an investigational dual-targeting BCMA/CD19 CAR-T therapy,  for the potential treatment of multiple myeloma...
FDA Grants Orphan Drug Designation to BCMA/CD19-Targeting CAR-T Therapy for Multiple Myeloma Treatment
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Healthy lifestyle interventions may be best started in preschool

By Linda Carroll (Reuters Health) - Implementing school-based programs aimed at teaching healthy cardiovascular habits starting in preschool can achieve lasting lifestyle changes in children, Read More »

Canada approves Pfizer's oral COVID-19 antiviral treatment, seeks supplies

By David Ljunggren and Ismail Shakil OTTAWA (Reuters) - Canada on Monday approved Pfizer Inc's oral antiviral treatment for mild to moderate cases of COVID-19 in people aged 18 and older but said Read More »

Secondhand vaping linked with respiratory symptoms in young adults

By Linda Carroll (Reuters Health) - Exposure to secondhand vape at home may be linked to a heightened risk for respiratory symptoms in young adults, a new study suggests. An analysis of data from Read More »

Pathological complete response likely not a reliable survival surrogate in early breast cancer

By Marilynn Larkin NEW YORK (Reuters Health) - A new meta-analysis suggests that pathological complete response (pCR) should not be used as a surrogate endpoint in randomized trials of neoadjuvant Read More »

Vaccine-like mRNA injection effectively treats cardiac fibrosis in mice

By Marilynn Larkin NEW YORK (Reuters Health) - A vaccine-like injection of modified mRNA temporarily reprogrammed immune cells to attack fibroblasts in a mouse model of heart failure, resulting in " Read More »

Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron

By Ari Rabinovitch JERUSALEM (Reuters) - A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a Read More »

South African hospital saw less serious disease with Omicron

By Reuters Staff (Reuters) - Doctors in one of the cities where Omicron was first identified say the surge driven by the new variant has been marked by less serious disease than earlier waves of the Read More »

Unique strings of molecules may predict variants' success

By Reuters Staff (Reuters) - Researchers believe they have discovered an important way to identify SARS-CoV-2 variants that are likely to spread. Looking at 9-unit strings of nucleotides - the Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.